Close-up digital rendering of molecular structure.
Our Work

Latham & Watkins Advises Boltz on US$110 Million Series A

November 18, 2026
Emerging Companies & Growth team represents the AI bio startup in the funding round.

Boltz, an AI research lab building foundation models for biomolecular modeling, small-molecule, and protein design, announced it has raised US$110 million in Series A funding. The funding round was led by Bessemer Venture Partners, with participation from existing investors including Andreessen Horowitz, Amplify Partners, Zetta Venture Partners, and Obvious Ventures, and new investors including Greycroft, F-Prime Capital, Hummingbird, and Benchling.

Latham & Watkins LLP represented Boltz in the funding round with an Emerging Companies & Growth team led by Boston partner Stephen Ranere, with associate Maayan Chinn.

Endnotes